Trials / Completed
CompletedNCT02577185
An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A
An Exploratory Psoriasis Plaque Test Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A as Tool Compound
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the anti-psoriatic effect of injected Botulinum toxin type A compared to that of injected vehicle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum Toxin Type A | |
| DRUG | Sodium chloride 9 mg/ml |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2015-10-16
- Last updated
- 2025-02-24
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02577185. Inclusion in this directory is not an endorsement.